Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in CNTA — Centessa Pharmaceuticals plc

CIK 1446194 BALA CYNWYD, PA

Position in CNTA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
17,737
+53.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CNTA Over Time

Shares Held

Position Value (USD)

Derivatives in CNTA

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
118,800
PutValue
$0
PutShares
173,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CNTA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 173,400
2026-03-31 17,737
2026-03-31 118,800
2025-12-31 160,500
2025-12-31 11,563
2025-12-31 96,700
2025-09-30 430,300
2025-09-30 77,700
2025-06-30 192,100
2025-06-30 69,000
2025-03-31 79,300
2025-03-31 899,505
2025-03-31 56,700
2024-12-31 15,746
2024-09-30 27,884
2024-09-30 23,500
2023-12-31 11,200
2023-09-30 18,500
2023-03-31 12,616